These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32926970)

  • 1. Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Gil-Redondo R; Ortega-Quijano D; Fernandez-Nieto D; Jaen-Olasolo P; Vaño-Galvan S
    J Am Acad Dermatol; 2021 Jan; 84(1):222-223. PubMed ID: 32926970
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse hypertrichosis during treatment with 5% topical minoxidil.
    Peluso AM; Misciali C; Vincenzi C; Tosti A
    Br J Dermatol; 1997 Jan; 136(1):118-20. PubMed ID: 9039309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
    Vañó-Galván S; Pirmez R; Hermosa-Gelbard A; Moreno-Arrones ÓM; Saceda-Corralo D; Rodrigues-Barata R; Jimenez-Cauhe J; Koh WL; Poa JE; Jerjen R; Trindade de Carvalho L; John JM; Salas-Callo CI; Vincenzi C; Yin L; Lo-Sicco K; Waskiel-Burnat A; Starace M; Zamorano JL; Jaén-Olasolo P; Piraccini BM; Rudnicka L; Shapiro J; Tosti A; Sinclair R; Bhoyrul B
    J Am Acad Dermatol; 2021 Jun; 84(6):1644-1651. PubMed ID: 33639244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized hypertrichosis after treatment with topical minoxidil.
    González M; Landa N; Gardeazabal J; Calderón MJ; Bilbao I; Díaz Pérez JL
    Clin Exp Dermatol; 1994 Mar; 19(2):157-8. PubMed ID: 8050148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minoxidil induced hypertrichosis in children.
    Guerouaz N; Mohamed AO
    Pan Afr Med J; 2014; 18():8. PubMed ID: 25360192
    [No Abstract]   [Full Text] [Related]  

  • 6. Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatory.
    Earhart RN; Ball J; Nuss DD; Aeling JL
    South Med J; 1977 Apr; 70(4):442-3. PubMed ID: 850811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy.
    Benmously Mlika R; Ben Hamida M; Hammami H; Dorbani Ben Thabet I; Rouatbi M; Mokhtar I
    J Cosmet Laser Ther; 2013 Aug; 15(4):217-8. PubMed ID: 23463948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrichosis in females applying minoxidil topical solution and in normal controls.
    Dawber RP; Rundegren J
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):271-5. PubMed ID: 12702063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral minoxidil improves background hair thickness in lichen planopilaris.
    Vañó-Galván S; Trindade de Carvalho L; Saceda-Corralo D; Rodrigues-Barata R; Kerkemeyer KL; Sinclair RD; Hermosa-Gelbard Á; Moreno-Arrones ÓM; Jimenez-Cauhe J; Bhoyrul B
    J Am Acad Dermatol; 2021 Jun; 84(6):1684-1686. PubMed ID: 32289397
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized Hypertrichosis Due to Topical Minoxidil.
    Gargallo V; Gutierrez C; Vanaclocha F; Guerra-Tapia A
    Actas Dermosifiliogr; 2015 Sep; 106(7):599-600. PubMed ID: 25688008
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
    Sanabria B; Vanzela TN; Miot HA; Müller Ramos P
    J Am Acad Dermatol; 2021 Apr; 84(4):1175-1178. PubMed ID: 33253848
    [No Abstract]   [Full Text] [Related]  

  • 12. Infantile generalized hypertrichosis caused by topical minoxidil.
    Rampon G; Henkin C; de Souza PR; Almeida HL
    An Bras Dermatol; 2016; 91(1):87-8. PubMed ID: 26982785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three percent topical minoxidil therapy for female androgenetic alopecia.
    Hordinsky MK; Shank J
    Clin Dermatol; 1988; 6(4):213-7. PubMed ID: 3214822
    [No Abstract]   [Full Text] [Related]  

  • 14. Piggyback-acquired hypertrichosis.
    Farsani TT; Kane MJ; Kane KS
    Pediatr Dermatol; 2014; 31(4):520-2. PubMed ID: 24915767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minoxidil and its use in hair disorders: a review.
    Suchonwanit P; Thammarucha S; Leerunyakul K
    Drug Des Devel Ther; 2019; 13():2777-2786. PubMed ID: 31496654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
    Sinclair RD
    Int J Dermatol; 2018 Jan; 57(1):104-109. PubMed ID: 29231239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hairy fall: syncope resulting from topical application of minoxidil.
    Dubrey SW; VanGriethuysen J; Edwards CM
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26347235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Fernandez-Nieto D; Vaño-Galvan S
    J Am Acad Dermatol; 2019 Aug; 81(2):648-649. PubMed ID: 31054970
    [No Abstract]   [Full Text] [Related]  

  • 19. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial.
    Ramos PM; Sinclair RD; Kasprzak M; Miot HA
    J Am Acad Dermatol; 2020 Jan; 82(1):252-253. PubMed ID: 31473295
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.
    Sharma AN; Michelle L; Juhasz M; Muller Ramos P; Atanaskova Mesinkovska N
    Int J Dermatol; 2020 Aug; 59(8):1013-1019. PubMed ID: 32516434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.